alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



Exhibit 31.2
 Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
      (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;(b)
    
    Designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;(c)
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and(d)
    
    Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and
  (a)
    
    All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; and(b)
    
    Any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal control over financial reporting.
  By:
    
    /s/ Lee E. BeckelmanName:
    
    Lee E. BeckelmanTitle:
    
    Vice President and Chief Financial Officer(Principal Financial Officer)
 42
**Exhibit32.2**

 

**CERTIFICATIONOF CHIEF FINANCIAL OFFICERPURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

I, Bruce Wright, certify, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that,to my knowledge:

 

•                  theQuarterly Report of Ultratech, Inc. on Form 10-Q for the quarterly period endedSeptember 27, 2003 fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•                  theinformation contained in such Quarterly Report fairly presents in all materialrespects the financial condition and results of operations of Ultratech, Inc.

 

 
|   | By:    | /s/ Bruce R. Wright*          |
|--------|--------|-------------------------------|
|   | Name:  |  Bruce Wright            |
|   | Title: |  Chief Financial Officer |

 

----

*A signed original of this written statement required bySection 906 has been provided to Ultratech, Inc. and will be retained byUltratech, Inc. and furnished to the Securities and Exchange Commission or itsstaff upon request.

 

----
**Exhibit 32.2**
**CERTIFICATION**
     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)and (b) of Section 1350, chapter 63 of title 18, United States Code), theundersigned officer of IPC Holdings, Ltd. (the “Company”), hereby certifies, tosuch officer’s knowledge, that:
The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30,2004 (the “Report”) fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 and the information contained inthe Report fairly presents, in all material respects, the financial conditionand results of operations of the Company.     Dated: November 9, 2004 /s/ John R. Weale   Name:/s/ John R. Weale Title:Chief Financial Officer
The foregoing certification is being furnished solely pursuant to Section 906of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350,chapter 63 of title 18, United States Code) and is not being filed as part ofthe Report.
TLSL, INC., petitioner, v. Rankin SNEAD, as Administrator Ad Litem of the Estate of Juan Estrada, et al.

No. 18-945.

Supreme Court of the United States

Feb. 25, 2019.

Petition for writ of certiorari to the Supreme Court of Alabama denied.
James TRAXLER, petitioner, v. Sherry BURT, Warden.

No. 18-7810.

Supreme Court of the United States

April 1, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
MIROWSKI FAMILY VENTURES, LLC, petitioner, v. MEDTRONIC, INC., et al.

No. 17-625.

Supreme Court of the United States

Jan. 16, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
EXHIBIT 32.1


                          SECTION 1350 CERTIFICATIONS

                  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
                1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


     In  connection  with the Form  10-KSB of DOMAIN  REGISTRATION,  CORP.  (the
"Company") on Form 10-KSB for the period ended  December 31, 2003 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I, Amy
Hadley,  President and Director of the Company,  certify,  pursuant to 18 U.S.C.
section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that based on my knowledge:

     1. The Report fully  complies  with the  requirements  of Section  13(a) or
15(d) of the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Date: March 30, 2004


/s/ AMY HADLEY
______________________________________
Amy Hadley
President and Director




A SIGNED  ORIGINAL OF THIS WRITTEN  STATEMENT  REQUIRED BY SECTION 906, OR OTHER
DOCUMENT AUTHENTICATING, ACKNOWLEDGING, OR OTHERWISE ADOPTING THE SIGNATURE THAT
APPEARS IN TYPED FORM WITHIN THE  ELECTRONIC  VERSION OF THIS WRITTEN  STATEMENT
REQUIRED BY SECTION 906, HAS BEEN PROVIDED TO DOMAIN REGISTRATION CORP. AND WILL
BE RETAINED BY DOMAIN  REGISTRATION  CORP.  AND FURNISHED TO THE  SECURITIES AND
EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.
Daniel H. KING, petitioner, v. UNITED STATES.

No. 18-7994.

Supreme Court of the United States

March 25, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
John Phillip BENDER, petitioner, v. Lorie DAVIS, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

No. 18-6051.

Supreme Court of the United States

March 25, 2019.

Petition for rehearing denied.
EXHIBIT 31.2

**CERTIFICATION**

I, Carroll A. Wallace, certify that:

1.  I have reviewed this 10-Q Report of Exabyte Corporation;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

c)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Dated: November 9, 2005

/s/ CARROLL A. WALLACE                                      

Carroll A. Wallace

Chief Financial Officer, Treasurer

(Principal Financial and Accounting Officer)
(LOGO) KPMG

700 Louisiana
Houston, TX 77002
Telephone 713 319 2000
Fax 713 319 2041


                         Independent Accountants' Report

The Board of Directors Bank United:

We have examined management's  assertion about Bank United and subsidiaries (the
Bank) compliance with the minimum servicing  standards set forth in the Mortgage
Bankers Association of America's Uniform Single Attestation Program for Mortgage
Bankers  as of and for the  year  ended  September  30,  1999,  included  in the
accompanying  Management  Assertion.  Management is  responsible  for the Bank's
compliance with those minimum  servicing  standards.  Our  responsibility  is to
express an opinion on management's  assertion about the Bank's  compliance based
on our examination.

Our  examination  was  made in  accordance  with  standards  established  by the
American  Institute of Certified Public Accountants and,  accordingly,  included
examining,  on a test  basis,  evidence  about the  Bank's  compliance  with the
minimum  servicing   standards  and  performing  such  other  procedures  as  we
considered  necessary  in the  circumstances.  We believe  that our  examination
provides a reasonable basis for our opinion.  Our examination does not provide a
legal  determination  on  the  Bank's  compliance  with  the  minimum  servicing
standards.

In our  opinion,  management's  assertion  that  the Bank  has  complied  in all
material respects with the aforementioned  minimum servicing standards as of and
for the year  ended  September  30,  1999,  is fairly  stated,  in all  material
respects.

KPMG LLP

October 26,1999
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Internal Revenue Service

# AGENCY:

Internal Revenue Service (IRS), Treasury.

# ACTION:

Notice of meeting.

# SUMMARY:

An open meeting of the Taxpayer Advocacy Panel's Taxpayer Assistance Center Improvements Project Committee will be conducted. The Taxpayer Advocacy Panel is soliciting public comments, ideas, and suggestions on improving customer service at the Internal Revenue Service. This meeting will still be held via teleconference.

# DATES:

The meeting will be held Thursday, June 9, 2022.

# FOR FURTHER INFORMATION CONTACT:

Matthew O'Sullivan at 1-888-912-1227 or (510) 907-5274.

# SUPPLEMENTARY INFORMATION:

                    Notice is hereby given pursuant to Section 10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) that an open meeting of the Taxpayer Advocacy Panel's Taxpayer Assistance Center Improvements Project Committee will be held Thursday, June 9, 2022, at 3:00 p.m. Eastern Time. The public is invited to make oral comments or submit written statements for consideration. Due to limited time and structure of meeting, notification of intent to participate must be made with Matthew O'Sullivan. For more information please contact Matthew O'Sullivan at 1-888-912-1227 or (510) 907-5274, or write TAP Office, 1301 Clay Street, Oakland, CA 94612-5217 or contact us at the website:                     *http://www.improveirs.org.*                     The agenda will include various IRS issues.                

Dated: May 3, 2022.

Kevin Brown,

Acting Director, Taxpayer Advocacy Panel.

[FR Doc. 2022-09825 Filed 5-5-22; 8:45 am]

BILLING CODE 4830-01-P
James Edward WHITNEY, petitioner, v. ARKANSAS.

No. 18-8344.

Supreme Court of the United States

April 15, 2019.

Petition for writ of certiorari to the Supreme Court of Arkansas denied.
Tommy Wayne BROTHERTON, petitioner, v. Jay CASSADY, Warden.

No. 18-7771.

Supreme Court of the United States

April 15, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
August 14, 2001


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549

Commissioners:

We are aware that our report dated August 10, 2001 on our review of interim
financial information of NB&T Financial Group, Inc. and Subsidiaries (the
"Company") as of and for the three-month and six-month periods ended June 30,
2001 and 2000 and included in the Company's quarterly report on Form 10-Q for
the quarter then ended is incorporated by reference in the Registration
Statement of the Company on Form S-8, filed on March 23, 1995.

Very truly yours,



/s/ J.D. Cloud & Co. L.L.P.
----------------------------
J.D. Cloud & Co. L.L.P.


Cincinnati, Ohio
```
 
 
WHEAT - KANSAS CITY BOARD OF TRADE                                   Code-001612
FUTURES ONLY POSITIONS AS OF 10/25/11                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(CONTRACTS OF 5,000 BUSHELS)                         OPEN INTEREST:      154,796
COMMITMENTS
  48,545   20,434   25,931   57,770   80,531  132,246  126,896   22,550   27,900

CHANGES FROM 10/18/11 (CHANGE IN OPEN INTEREST:     -2,336)
  -1,443   -1,035   -1,909      605      199   -2,747   -2,745      411      409

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    31.4     13.2     16.8     37.3     52.0     85.4     82.0     14.6     18.0

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      173)
      55       29       50       59       64      130      133
```

----

Updated October 28, 2011
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with The Beard Company’s (the “Company”) Report on Form 10-Q for the period  ended June 30,  2006, as filed with the  Securities  and  Exchange Commission on the date hereof (the “Report”), I, William M. Beard, Chairman of the Board and Chief Executive  Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|----|-----------------------------------------------------------------------------------------------------------------------------------|
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------|

 
|                   |                                                                                                           |
|------------------------|----------------------------------------------------------------------------------------------------------------|
| Date:  August 14, 2006 | By:  /s/ William M. Beard

William M. BeardChairman of the Board and    Chief Executive Officer |
# Úradný vestník C 509I/2021

| | ISSN 1977-1037 |
| --- | --- |
| Úradný vestník
  Európskej únie | C 509I |
| | |
| Slovenské vydanie | Informácie a oznámenia | Ročník 6417. decembra 2021 |

ISSN 1977-1037

Úradný vestník

Európskej únie

C 509I

Slovenské vydanie

Informácie a oznámenia

Ročník 6417. decembra 2021

---

| Obsah | Strana |
| --- | --- |
| | IV   Informácie |
| | INFORMÁCIE INŠTITÚCIÍ, ORGÁNOV, ÚRADOV A AGENTÚR EURÓPSKEJ ÚNIE |
| | Európska komisia |
| 2021/C 509 I/01 | Súhrn rozhodnutí Európskej únie o povolení na uvedenie liekov na trh zo 17. decembra 2021
  [Uverejnené v súlade s článkom 13 alebo 38 nariadenia Európskeho parlamentu a Rady (ES) č. 726/2004] | 1 |

Obsah

Strana

IV   Informácie

INFORMÁCIE INŠTITÚCIÍ, ORGÁNOV, ÚRADOV A AGENTÚR EURÓPSKEJ ÚNIE

Európska komisia

2021/C 509 I/01

Súhrn rozhodnutí Európskej únie o povolení na uvedenie liekov na trh zo 17. decembra 2021
  [Uverejnené v súlade s článkom 13 alebo 38 nariadenia Európskeho parlamentu a Rady (ES) č. 726/2004]

[Uverejnené v súlade s článkom 13 alebo 38 nariadenia Európskeho parlamentu a Rady (ES) č. 726/2004

1

---

| SK | |
| --- | --- |

SK

---

IV Informácie

INFORMÁCIE INŠTITÚCIÍ, ORGÁNOV, ÚRADOV A AGENTÚR EURÓPSKEJ ÚNIE

Európska komisia

| 17.12.2021 | SK | Úradný vestník Európskej únie | CI 509/1 |
| --- | --- | --- | --- |

17.12.2021

SK

Úradný vestník Európskej únie

CI 509/1

---

Súhrn rozhodnutí Európskej únie o povolení na uvedenie liekov na trh zo 17. decembra 2021

[Uverejnené v súlade s článkom 13 alebo 38 nariadenia Európskeho parlamentu a Rady (ES) č. 726/2004 (1)]

(2021/C 509 I/01)

| — | Udelenie povolenia na uvedenie na trh [článok 13 nariadenia Európskeho parlamentu a Rady (ES) č. 726/2004]: Prijaté













  Dátum rozhodnutia | Názov lieku | INN (medzinárodný neregistrovaný názov) | Držiteľ povolenia na uvedenie na trh | Číslo záznamu v registri Spoločenstva | Lieková forma | Kód ATC (anatomicko-terapeuticko-chemický kód) | Dátum oznámenia |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 17.12.2021 | Xevudy | sotrovimab | GlaxoSmithKline Trading Services Limited
  Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland | EU/1/21/1562 | Koncentrát na infúzny roztok | Pending | 17.12.2021 |

—

Udelenie povolenia na uvedenie na trh [článok 13 nariadenia Európskeho parlamentu a Rady (ES) č. 726/2004]: Prijaté

Dátum rozhodnutia

Názov lieku

INN (medzinárodný neregistrovaný názov)

Držiteľ povolenia na uvedenie na trh

Číslo záznamu v registri Spoločenstva

Lieková forma

Kód ATC (anatomicko-terapeuticko-chemický kód)

Dátum oznámenia

17.12.2021

Xevudy

sotrovimab

GlaxoSmithKline Trading Services Limited

Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

EU/1/21/1562

Koncentrát na infúzny roztok

Pending

17.12.2021

Ak sa chcete oboznámiť s verejnou hodnotiacou správou o príslušných liekoch a s ňou súvisiacimi rozhodnutiami, môžete kontaktovať:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NETHERLANDS |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

---

(1)  Ú. v. EÚ L 136, 30.4.2004, s. 1.

---
Marvin JOHNSON, petitioner, v. UNITED STATES.

No. 18-8217.

Supreme Court of the United States

April 1, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
23.  Consent of Armando Iberra CPA

                                ARMANDO C. IBARRA
                          CERTIFIED PUBLIC ACCOUNTANTS
                          (A Professional Corporation)
                      350 E. Street, Chula Vista, CA 91910
                     Tel: (619) 422-1348 Fax: (619) 422-1465


Armando C. Ibarra,
C.P.A.
Members of the California Society of
Armando Ibarra, Jr.,
C.P.A.
Certified Public Accounts


May 8, 2002


Everclear International, Inc.
(Formerly Shaw International, Inc.)
6025 South Eaton Lane
Littleton, Colorado, USA 80123



Re: Shaw International, Inc.


This is to confirm that we consent to the use of our December 31, 2001 audited
financial statements of Everclear International, Inc. in your required SEC
filings including the 10k report.




Sincerely,


-------------------------
ARMANDO IBARRA, C.P.A.
Luther Gene RAY, petitioner, v. UNITED STATES.

No. 18-7700.

Supreme Court of the United States

March 4, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.